General Information of the Compound
Compound ID
CP0450219
Compound Name
US8802711, 66
    Show/Hide
Synonyms
PMID25666693-Compound-14
    Show/Hide
Structure
Formula
C19H19FN4O
Molecular Weight
338.386
Canonical SMILES
Fc1ccccc1[C@@H]1CC[C@H](C1)NC(=O)Nc1cccc2[nH]ncc12
    Show/Hide
InChI
InChI=1S/C19H19FN4O/c20-16-5-2-1-4-14(16)12-8-9-13(10-12)22-19(25)23-17-6-3-7-18-15(17)11-21-24-18/h1-7,11-13H,8-10H2,(H,21,24)(H2,22,23,25)/t12-,13-/m1/s1
    Show/Hide
InChIKey
MNXPYZUSFURMKS-CHWSQXEVSA-N
Physicochemical Property
logP
4.1598
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
69.81
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
2
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 60202428
SID: 144221621
ChEMBL ID
CHEMBL3644121
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 8.2 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( PMID25666693-Compound-14 )
Drug Name PMID25666693-Compound-14
Company ABBVIE INC
Indication
Osteoarthritis pain
Patented
Cancer related pain
Patented
Neuropathic pain
Patented
Inflammatory pain
Patented
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Antagonist